Oramed Pharmaceuticals, Inc. (ORMP)
4.77
+0.07
(+1.49%)
USD |
NASDAQ |
Sep 22, 11:23
Oramed Pharmaceuticals Total Long Term Debt (Quarterly) : 0.484M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.484M |
| March 31, 2026 | 0.493M |
| December 31, 2025 | 0.54M |
| September 30, 2025 | 0.589M |
| June 30, 2025 | 0.648M |
| March 31, 2025 | 0.12M |
| December 31, 2024 | 0.156M |
| September 30, 2024 | 0.186M |
| June 30, 2024 | 0.236M |
| March 31, 2024 | 0.272M |
| December 31, 2023 | 0.342M |
| September 30, 2023 | 0.389M |
| June 30, 2023 | 0.488M |
| March 31, 2023 | 0.564M |
| December 31, 2022 | 0.647M |
| September 30, 2022 | 0.672M |
| June 30, 2022 | 0.744M |
| March 31, 2022 | 0.871M |
| August 31, 2021 | 0.403M |
| May 31, 2021 | 0.431M |
| February 28, 2021 | 0.469M |
| November 30, 2020 | 0.502M |
| August 31, 2020 | 0.031M |
| May 31, 2020 | 0.057M |
| February 29, 2020 | 0.067M |
| Date | Value |
|---|---|
| November 30, 2019 | 0.06M |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.00 |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.00 |
| November 30, 2014 | 0.00 |
| August 31, 2014 | 0.00 |
| May 31, 2014 | 0.00 |
| February 28, 2014 | 0.00 |
| November 30, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Eli Lilly & Co. | 49.62B |
| Pfizer Inc. | 63.10B |
| Liquidia Corp. | 182.90M |
| Scilex Holding Co. | 101.51M |
| BioAge Labs, Inc. | 2.121M |